# Cardinal Health, Inc. (CAH) FY2025 Q3 Balance Sheet

- Company: Cardinal Health, Inc. (CAH)
- Period: As of 2025-03-31
- Filing: Q3 FY2025 10-Q, filed 2025-05-01, accession number 0000721371-25-000038
- Page: https://plicit.ai/financials/cah/fy2025-q3-balance-sheet
- Chart image: https://plicit.ai/charts/cah-fy2025-q3-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 49,871,000,000 US dollars
- **Current assets**: 34,595,000,000 US dollars
- **Non-current assets**: 15,276,000,000 US dollars
- **Liabilities (calculated)**: 51,769,000,000 US dollars
- **Current liabilities**: 36,662,000,000 US dollars
- **Non-current liabilities**: 15,107,000,000 US dollars
- **Equity**: negative 1,898,000,000 US dollars
- **Noncontrolling interest**: 1,050,000,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Inventories, net**: 16,158,000,000 US dollars
- **Trade receivables, net**: 12,666,000,000 US dollars
- **Cash and equivalents**: 3,326,000,000 US dollars
- **Prepaid expenses and other**: 2,398,000,000 US dollars
- **Assets held for sale**: 47,000,000 US dollars
- **Goodwill and other intangibles, net**: 11,014,000,000 US dollars
- **Property and equipment, net**: 2,664,000,000 US dollars
- **Other assets**: 1,598,000,000 US dollars
- **Accounts payable**: 32,812,000,000 US dollars
- **Other accrued liabilities**: 3,307,000,000 US dollars
- **Current portion of long-term obligations and other short-term borrowings**: 543,000,000 US dollars
- **Deferred income taxes and other liabilities**: 7,971,000,000 US dollars
- **Long-term obligations, less current portion**: 7,136,000,000 US dollars
- **Authorized—755 million shares, Issued—271 million shares and 327 million shares at March 31, 2025 and June 30, 2024, respectively**: 2,946,000,000 US dollars
- **Retained earnings/(accumulated deficit)**: 664,000,000 US dollars
- **Authorized—500 thousand shares, Issued—none**: 0 US dollars
- **Noncontrolling interests**: 1,050,000,000 US dollars
- **Common shares in treasury, at cost: 32 million shares and 83 million shares at March 31, 2025 and June 30, 2024, respectively**: negative 6,382,000,000 US dollars
- **Accumulated other comprehensive loss**: negative 176,000,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.